论文部分内容阅读
AIM To investigate serum PC-594 fatty acid levels asa potential biomarker in North American pancreaticcancer (PaC) patients, and to compare its performanceto CA19-9.METHODS: Using tandem mass spectrometry, weevaluated serum PC-594 levels from 84 North Ame